As Per the Report, the Latin America Organ Preservation Market size is valued at USD 13.37 million in 2022 and estimated to grow at a CAGR of 6.5%, to reach USD 18.31 million by 2027 during the forecast period 2022 to 2027.
The global organ preservation market is primarily driven by the high prevalence of organ failure, the increased advancements in surgeries, the growing number of transplant procedures, and the growing penetration of many products.
The increasing prevalence of cardiovascular disease and the increase in the elderly population leading to organ failure are likely to improve the growth of organ preservation. In addition, factors such as increasing government initiatives and reimbursement policies on advanced medical treatment options and increasing demand for technologically advanced treatments are likely to enhance the growth of the organ preservation market in the Latin Americas region. For example, according to the American Heart Association, in 2018, about 27% of deaths in the Latin America were due to cardiovascular disorders. According to the National Chronic Kidney Disease Report, chronic kidney disease is common among adults in the Latin America, and 17 million people, or 12% of adults, are expected to have chronic kidney disease. This increasing rate of cardiovascular and renal disorders is expected to have a direct effect on organ preservation as the demand for organ transplants increases.
The market is expected to grow during the forecast period owing to the availability of advanced treatment facilities and spending on medical care, and the increase in cases of alcoholic fatty liver disease which can lead even further to liver failure. In addition, various government legislative reforms providing regulatory guidance to manufacturing companies and the burgeoning medical device market are attributed to the presence of key pharmaceutical companies in this region, which will ultimately boost the market. In addition, the increasing prevalence of cardiovascular disorders, renal disorders as well as the increase in the elderly population which would ultimately increase the population of patients with organ failure, will complement the growth of the organ preservation market.
The high cost of organ preservation and transplantation procedures along with extensive research and development to grow organs using stem cell therapy may hinder the growth of the organ preservation market.
Additionally, factors such as government and NGO initiatives to encourage organ donation and the availability of skilled personnel are likely to drive the market growth.
Lack of availability of the right donor and organ development through stem cell therapy are likely to hold back the growth of the market. The results were disappointing and the program for the transplantation of solid organs, with the exception of the kidneys, was generally suspended.
This research report on the Latin America Organ Preservation Market has been segmented and sub-segmented into the following categories
By Preservation Solution:
By Transportation Technique:
By Organ Type:
Currently, Brazil ranks high among all countries in terms of the number of transplants performed and has the highest level of public funding for this procedure; 96% of transplants in the country are funded by the SUS (public health system).
Despite all the interest and efforts, transplantation in Mexico faces several challenges. In particular, the increase in authorized centers has not contributed to an increase in the number of transplants since most authorized centers have a very low volume. In addition, a considerable number of accredited centers are inactive, most often for various reasons, including lack of financial support, institutional commitment, inadequate infrastructure combined with a general shortage of donors in the country.
Noteworthy Companies leading the Latin America Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org